25 participants
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-17
- Start Date:
- 2026-07-31
- Completion:
- 2031-07-31
Conditions
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
Interventions
- DRUG
No Results Yet